Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Viscofan SA is a Spanish multinational and the global leader in manufacturing artificial casings for meat products, serving the food industry with innovative packaging solutions. Founded in 1975 and headquartered in Navarra, it produces cellulose, collagen, fibrous, plastic, and vegetable-based casings, including functional solutions like Viscofan Veggie and eFAN, tailored for sausages, hams, cheeses, and other processed foods. The company also offers plastic films, shrink bags, and diversification products such as collagen biomatrices for medical, nutraceutical, and health applications through its New Business division. With production facilities in 13 countries across EMEA, North America, Asia-Pacific, and South America, and commercial presence in over 100 markets, Viscofan SA employs around 5,300 professionals committed to a culture of innovation, sustainability, and excellence. Its Beyond25 strategic plan emphasizes leadership in traditional casings while expanding into wellness and health sectors, leveraging proprietary technologies, R&D, and a vast product portfolio of over 13,000 items to meet evolving consumer demands for convenience, health, and reduced food waste.
€58.00
+€0.10 (+0.17%)
EOD Jun 23, 2026 · Twelve Data
16.31% operating margin is respectable but not wide. ROIC at 15.50%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 4.0%, steady but not accelerating. Free cash flow declined 29% despite revenue growth, conversion is weakening.
Free cash flow declined 29% versus the prior year, cash generation momentum has weakened.
16.3x earnings, 22.9x FCF. Valuation is in a reasonable range. The main question is whether the business can re-accelerate or if current trajectory is already priced in.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€1.25B
▲ +4.0% YoY
Net Income (TTM)
€160M
▲ +0.7% YoY
Op. Margin
15.96%
▼ -0.5pp YoY
ROIC
15.50%
▲ +2.2pp YoY
Cash Flow & Balance Sheet
FCF (FY)
€115M
▼ -28.5% YoY
Op. Cash Flow (FY)
€148M
▼ -8.1% YoY
Net Debt
€216M
Cash & Equiv.
€64M
3Y CAGR: +1.4%
3Y CAGR: +181.3%
Continue Research